Breaking News

You are here » Indian-Commodity  :  Corporate  :  Wanbury successfully completes USFDA inspection at its API facility in Patalganga Plant

01-Oct2016

Wanbury successfully completes USFDA inspection at its API facility in Patalganga Plant

Wanbury has successfully completed US Food and Drug Administration (USFDA) inspection a at its API facility in Patalganga Plant, Maharashtra. The audit was carried out for a period of 4 days from September 26 to September 29, 2016 and concluded successfully. This is the second plant to be approved by USFDA this year, as earlier Tanuku Plant got approval two months ago in July 2016.

Wanbury, one of India's fastest growing pharmaceutical companies amongst the 'Top 50 Companies' in India (as per ORG-IMS), has a strong presence in API global market and domestic branded Formulation. The company's major thrust area lies in Active Pharmaceutical Ingredient (API) sale in over 70 countries and Pan-India Formulation presence.



Related News

View all news

DCB Bank reports 25% rise in Q2 net profit

DCB Bank has reported results for second quarter ended September 30, 2018.The Bank has reported 24.69% rise in its net profit at Rs 73.44 crore for the quarter under review as compared to Rs 58.90 crore......

Persistent Systems, Partners HealthCare launch new center of excellence

Partners HealthCare in collaboration with Persistent Systems has formed a new center of excellence - Partners HealthCare Pivot Labs that aims to disrupt the delivery of healthcare to enhance the patient......

IndiGo makes Hong Kong as its 15th international destination

InterGlobe Aviation (IndiGo) has made Hong Kong as its 15th international destination. The airline to operate its daily non-stop flight between Hong Kong and Bangalore effective December 11, 2018. As part......

Top News

View all news

IRB Infrastructure's arm achieves financial closure for Vadodara-Mumbai Expressway project

IRB Infrastructure Developers' Wholly-owned Subsidiary (SPV) -- VK1 Expressway has achieved financial closure for the project of construction of eight lane Vadodara Kim Expressway from Km 355.00 to Km......

Havells India reports 4% rise in Q2 net profit

Havells India has reported results for second quarter ended September 30, 2018.The company has reported 4.44% rise in its net profit at Rs 178.62 crore for the quarter under review as compared to Rs 171.02......

Mphasis reports 37% rise in Q2 consolidated net profit

Mphasis has reported results for second quarter ended September 30, 2018.The company has reported a rise of 9.42% in its net profit of Rs 188.94 crore for the quarter under review as compared to Rs 172.67......